| K-number | K251323 |
| Device name | Device 104 Particulate |
| Applicant | Geistlich Pharma AG |
| Product code | KGN |
| Device class | Class U |
| Decision date | Jan 22, 2026 |
| Decision | Substantially Equivalent |
| Regulation | — |
The FDA summary PDF for this submission is not available in machine-readable form — common for older clearances. View on FDA's site →
View the full FDA submission: accessdata.fda.gov